Investment
Features
FeesSafety
Academy
More
Pluang+

Compare SMX Security Matters plc (SMX) vs Tilray Brands Inc (TLRY) Price & Performance

SMX Security Matters plcTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

SMX Security Matters plc vs Tilray Brands Inc — how do they compare? SMX Security Matters plc trades at $3.84 (market cap $4.13M), while Tilray Brands Inc trades at $3.53 (market cap $530.54M). The key difference: Tilray Brands Inc is far larger — about 128.5× SMX Security Matters plc's market cap, and SMX Security Matters plc is more actively traded (124,362 versus 9,099,075). Which is the better fit depends on your goals — on Pluang, investors hold SMX Security Matters plc for 21 Days and Tilray Brands Inc for 31 Days on average.

SMXTLRY
Market Cap
$4.13M$530.54M
Volume
124,3629,099,075
Sector
IndustrialsHealth
52-Week High
$74.08K$21.00
52-Week Low
$3.79$3.57
Typical Hold Time
21 Days31 Days
Enterprise Value
-$27.20M$684.46M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

SMX Security Matters plc

SMX trades at $3.80, down 2.56% with a bearish technical outlook despite oversold RSI readings. The company shows severe financial distress with no revenue, negative EBITDA of -$130.44M, and deeply negative ROE of -819.22%. Recent news highlights SMX's digital material passport technology gaining media attention from Forbes, TIME, and Boston Herald in September-October 2026, focusing on recycled plastic verification and circular economy applications.

The stock faces substantial fundamental challenges with no current revenue generation and significant operating losses. While media coverage suggests technological potential in material verification, the absence of revenue and massive negative profitability metrics present extreme risk. Investment viability depends entirely on SMX's ability to monetize its technology platform amid ongoing cash burn.

Tilray Brands Inc

Tilray Brands (TLRY) trades at $3.50, down 5.79% on the day and near its 52-week low. The stock shows bearish technical signals with negative moving averages and recent earnings misses across four consecutive quarters. Despite revenue growth to $821 million in 2025, the company reported a substantial net loss of $2.19 billion, driven by impairment charges and high operating costs. Analyst sentiment remains cautious with 65% hold ratings, though the consensus price target of $65.01 suggests significant potential upside from current levels.

The outlook remains challenging with persistent profitability issues and negative cash flow from operations. Investment opportunity exists if Tilray can achieve projected 2026 revenue growth to $915 million and reduce losses. Key risks include ongoing operational inefficiencies, competitive pressures in the cannabis market, and regulatory uncertainty. The stock's current valuation at 0.44 P/S and 0.33 P/B may attract value investors betting on a turnaround.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SMX
71% Buy29% Sell
Avg holding period · 21 Days
TLRY
54% Buy46% Sell
Avg holding period · 31 Days

Top news

Latest headlines on both assets

About SMX Security Matters plc

SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.

Read more on SMX →

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY →